GEN Exclusives

More »

GEN Poll

More »
Aug 01, 2012

New Treatments for Alzheimer’s Disease

The global market value of Alzheimer’s disease (AD) therapeutics could soar to the $8 billion range once therapeutics are approved that actually change the course of the disease. More than 150 companies are working on new treatments for AD, including approximately 15 multinationals and 30 generics companies. Which new therapies do you think will be most successful at treating AD?

Which new Alzheimer’s disease treatments do you think have the best chance of success?

Bapineuzumab
 
  18.2%
Antisenilin
 
  9.1%
Gammagard
 
  20.8%
Gantenerumab
 
  9.1%
Other
 
  42.9%

More Polls » View Results »

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?